Maarten Altelaar develops and implements novel MS based proteomics technologies to study protein regulation and cellular signaling processes. Emphasis lies on neuronal cell differentiation and cancer signaling in acquired drug resistance and immune therapy. High-throughput (phospho)proteomics complemented with top-down MS technologies are used to target proteome dynamics.
Highlighted publications
See my citations on Google Scholar
- [PMID]25538140[/PMID]
- [PMID]24961811[/PMID]
- [PMID]25518064[/PMID]
- [PMID]23581470[/PMID]
- [PMID]23360999[/PMID]
- [PMID]23207911[/PMID]
[profilelist pi=”maarten-altelaar” orderby=”last_name”]
